Repository logo
  • English
  • 中文
Log In
Have you forgotten your password?
  1. Home
  2. College of Medicine / 醫學院
  3. School of Medicine / 醫學系
  4. Sparing Immunosuppression in Heart Transplant Recipients With Severe Sepsis
 
  • Details

Sparing Immunosuppression in Heart Transplant Recipients With Severe Sepsis

Journal
Transplantation Proceedings
Journal Volume
38
Journal Issue
7
Pages
2145-2146
Date Issued
2006
Author(s)
NAI-KUAN CHOU  
Ko W.J.
NAI-HSIN CHI  
YIH-SHARNG CHEN  
HSI-YU YU  
RON-BIN HSU  
CHI-TAI FANG  
SHAN-CHWEN CHANG  
Lin F.Y.
Chu S.H.
SHOEI-SHEN WANG  
DOI
10.1016/j.transproceed.2006.06.009
URI
https://www.scopus.com/inward/record.uri?eid=2-s2.0-33846092060&doi=10.1016%2fj.transproceed.2006.06.009&partnerID=40&md5=d558d2d37650453a1c95b08c09a5ba60
https://scholars.lib.ntu.edu.tw/handle/123456789/434146
Abstract
This study described an analysis of severe sepsis among heart transplantation recipients who were treated by sparing all immunosuppressants. Sepsis leading to multiple organ failure (MOF) in heart transplantation has a high mortality. This retrospective study of 190 patients who underwent heart transplantation from 1993 to 2004 included 12 who had severe sepsis with MOF who were treated by sparing all immunosuppressants. Half of them survived after sparing all immunosuppressants with intensive endomyocardial biopsy. Only one case needed pulse therapy for an acute rejection episode. The most common bacterial infectious episodes were caused by methicillin-resistant Staphylococcus aureus (n = 3). All sepsis episodes occurred in the first month after heart transplantation except in one case, which occurred 6 years after heart transplantation. There was a 50% survival rate of heart transplantation recipients who experienced MOF due to severe sepsis and were treated by sparing all immunosuppressants under a program of intensive endomyocardial biopsy. ? 2006 Elsevier Inc. All rights reserved.
SDGs

[SDGs]SDG3

Other Subjects
cefazolin; immunosuppressive agent; nystatin; steroid; article; bacterial infection; cardiac graft rejection; drug pulse therapy; graft recipient; heart muscle biopsy; heart transplantation; human; human tissue; major clinical study; methicillin resistant Staphylococcus aureus; mortality; multiple organ failure; oropharynx candidiasis; postoperative complication; priority journal; retrospective study; sepsis; survival rate; Bacterial Infections; Candidiasis; Dose-Response Relationship, Drug; Heart Transplantation; Humans; Immunosuppressive Agents; Multiple Organ Failure; Retrospective Studies; Sepsis
Type
journal article
File(s)
Loading...
Thumbnail Image
Name

39.pdf

Size

56.17 KB

Format

Adobe PDF

Checksum

(MD5):6560d2121deb24ee5681d5719c29935f

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Open policy finder網站查詢,以確認出版單位之版權政策。
    Please use Open policy finder to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science